Risk factors for loneliness in family caregivers of people with dementia and enduring mental health conditions during the COVID‐19 pandemic in Latin America
Tomás León(University of Phoenix), Roger O’Sullivan(University of Ulster), Yaohua Sophie Chen(Trinity College Dublin), Mireya Vilar‐Compte(World Bank Group), Claudia Duran‐Aniotz(Adolfo Ibáñez University), Loreto Olavarría(Universidad de Santiago de Chile), Emilia Grycuk(Trinity College Dublin), Alejandra Pinto, Andrea Slachevsky(Universidad del Desarrollo), Bárbara Costa Beber(Universidade Federal de Ciências da Saúde de Porto Alegre), Pablo Gaitan(Ibero American University), Loreto Castro(Clínica MEDS (Chile)), Thamara Tapia‐Muñoz(Millennium Science Initiative), Iracema Leroi(Trinity College Dublin), Fernando Aguzzoli Peres(University of California, San Francisco), Carla Nubia(Universidade Federal de Ciências da Saúde de Porto Alegre), Brian Lawlor(Trinity College Dublin), Claudia Miranda‐Castillo(Universidad Andrés Bello)
Cited by 3
Related Papers
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
|JAMA Neurology|2024|355
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223